Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Methotrexate |
ILD - ESCA |
|
|
|
Methotrexate 2.5mg tablets |
Supported with an ESCA. Methotrexate tablets - use 2.5mg strength ONLY. Methotrexate injection - Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
|
Methotrexate injections |
Supported with an ESCA. Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
|
Methotrexate tablets (2.5mg) |
ESCA. Methotrexate tablets - use 2.5mg strength only. Methotrexate injection - Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
|
Methotrexate#13.5 |
ESCA |
|
|
|
Methyldopa tablets | ||
|
|
Methylphenidate tablets#Amber |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Metolazone |
Specialist recommendation (unlicensed). There is now a UK licensed metolazone 5mg tablet available (Xaqua®). There are significant differences in bioavailability between Xaqua® and alternative unlicensed imported metolazone preparations. Xaqua® tablets have up to approximately twice the bioavailability of other metolazone preparations. If switching from another metolazone product to Xaqua® tablets or vice versa, a dose adjustment may be necessary, and individualised titration based on patient's response and tolerability is advised. More information available from Specialist Pharmacy Service (SPS). We are awaiting guidance on switching to the licensed product – in the mean time please ensure that the patients are not inadvertently switched between products. |
|
|
|
Mexiletine hydrochloride 100mg & 200mg capsules |
Unlicensed. Use with local trust approval. Available from "Special order" manufacturers or specialist importing companies. |
|
|
|
Mezavant XL |
